04.05.23 -- Scaling Cell & Gene Manufacturing, Gene Writing, TCRs in Personalized Oncology and more new episodes out now!
04/05/23 Life Science Leader Newsletter
Source: lifescienceleader.com
Akihiro Ko News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Akihiro Ko. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Akihiro Ko Today - Breaking & Trending Today
Elixirgen Therapeutics Appoints Jeffrey L. Cleland, Ph.D., to Board of Directors
Elixirgen Therapeutics Appoints Jeffrey L. Cleland, Ph.D., to Board of Directors - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Elixirgen Therapeutics Announces Dosing of First and Second Participants in its COVID-19 Vaccine Phase 1/2 Clinical Trial at Fujita Health University
Share this article Share this article BALTIMORE, May 25, 2021 /PRNewswire/ -- Elixirgen Therapeutics, Inc., a Baltimore-based biotechnology company focused on the discovery and development of therapies for genetic diseases and vaccines, today announced the dosing of the first and second participants in its COVID-19 vaccine Phase 1/2 Clinical Trial in Japan. The vaccine, called EXG-5003, is an intradermally-injected, temperature-controllable, self-replicating RNA vaccine expressing the receptor binding domain of the SARS-CoV-2 spike protein. Elixirgen Therapeutics Announces First Dosing of C...
Source: prnewswire.com